Related Experiment Videos
Visual hallucinations and the Charles Bonnet syndrome
1Centre for Neuroimaging Sciences, Institute of Psychiatry, PO 89 De Crespigny Park, Denmark Hill, London SE5 8AF, United Kingdom. d.ffytche@iop.kcl.ac.uk
Current Psychiatry Reports
|June 7, 2005
Summary
Charles Bonnet syndrome, characterized by visual hallucinations, is re-examined. New neurobiological insights suggest two distinct syndromes, prompting a reevaluation of classification and management strategies for this common symptom.
Area of Science:
- Neuroscience
- Ophthalmology
- Psychiatry
Background:
- Charles Bonnet syndrome (CBS) has lacked a unified definition for decades.
- Current definitions vary, encompassing visual hallucinations associated with age, eye disease, or as a general phenomenological description.
- Existing classifications fail to define a specific clinical entity or explain hallucinations across diverse conditions.
Purpose of the Study:
- To reassess the classification and management of Charles Bonnet syndrome.
- To explore recent neurobiological insights into vision and visual hallucinations.
- To propose a revised framework based on neuro-phenomenology.
Main Methods:
- Review of clinical evidence through a neuro-phenomenologic lens.
- Integration of recent findings in the neurobiology of vision.
- Analysis of visual hallucinations across a spectrum of associated clinical conditions.
Main Results:
- Clinical evidence suggests two distinct visual hallucination syndromes.
- Syndrome 1: Directly linked to visual system pathology.
- Syndrome 2: Associated with brainstem or ascending neurotransmitter pathway pathology.
Conclusions:
- Two independent but interacting pathophysiologic mechanisms likely underlie visual hallucinations.
- A reassessment of the classification and management of Charles Bonnet syndrome is warranted.
- Distinguishing between visual system and central nervous system pathways is crucial for understanding and treating these hallucinations.